The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
447
Change from baseline to final visit in the YMRS total score
Change from baseline to each visit in YMRS score and changes of YMRS subscores and changes in MADRS.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Phoenix, Arizona, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Cerritos, California, United States
Research Site
Garden Grove, California, United States
Research Site
Oceanside, California, United States
Research Site
Pico Rivera, California, United States
Research Site
San Diego, California, United States
Research Site
Santa Ana, California, United States
Research Site
Torrance, California, United States
Research Site
Denver, Colorado, United States
...and 41 more locations